A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

How Drones are Revolutionising Medical Delivery

Over the last decade or so, there’s been a quiet revolution in logistics. Same day delivery in the UK is now a common thing – and this has been good news in the world of medicine.

One exciting area of development is unmanned aerial vehicles. They’re now quite a commonplace consumer product, used for everything from recreation to photography to surveillance.

One of the more exciting aspects of the technology, however, is its ability to deliver medical supplies. Drones can get from one place to another extremely quickly, and they’re not slowed down by terrain in the same way as road vehicles. This means that care can be provided much more quickly. In some cases, this can make a dramatic difference in outcomes for patients.

The current outlook on the usage of medicine drones

In 2018, it was estimated that the global market for medicine drones will push beyond the $100 million mark by 2025. Drones have already distributed millions of vaccines, blood packs, and medical supplies. Recently, the government in Rwanda announced a partnership with drone company Zipline. The company already delivers around three quarters of the country’s blood supply.

How drones are already helping save lives

While it’s easy to think of logistics as a dry, abstract thing, in this context the benefits of efficiency are clear. If a patient is deteriorating, any delay might spell the difference between life and death. And when the road infrastructure isn’t up to standard, these delays are all too common.

Unmanned vehicles can be launched within around ninety seconds of an order being placed. Since the entire system is autonymous, it can operate continuously. Drones can even fly just as easily at night time as they can during the day, since they don’t need to be able to see where they’re going in the same way as human pilots.

Challenges to overcome

There are a few potential downsides to this form of delivery. If the technology is to reach its full potential, these will each need to be addressed.

The first concerns privacy. A drone that flies over your property can look down and see into your back garden.

The second has to do with noise pollution. But, while many of the drones that have reached consumers in recent years have been driven by four propellers, those used by Zipline follow a different design, which is near-silent, especially from ground level. This means that the number of vehicles could be scaled up without causing too much noise.

Finally, we need to ensure that the technology is completely safe – or, at least, safer than the alternatives might be. This will involve a continuous process of refinement and redesign, as the technology is rolled out, and flaws are gradually revealed.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy